France First to Act on HHC in Europe

France First to Act on HHC in Europe

France has recently moved to stem the sale of synthetic cannabinoid HHC, an intoxicating hemp-derived product like delta-8 THC.  As of yesterday, June 13, HHC is classified as a drug and all further sales are banned.

The policy shift is guided by research showing that HHC “presents the same risk of abuse and dependence as cannabis,” the French National Agency for the Safety of Medicines and Health Products (ANSM) said.

Membership is required to view the rest of this post.
Click here to learn more and sign up for a free 7-day trial!

Blog

12.27.2024

US RD, SAF supplies remain strong despite declining import volumes

US RD, SAF supplies remain strong despite declining import volumes

US supplies of sustainable aviation fuel (SAF) fell sharply in November but reached the highest November volume on record, according to data released on Thursday December 26 by the...

12.27.2024

Animal fats and oils end week steady amid holiday-limited trades

Animal fats and oils end week steady amid holiday-limited trades

The US animal fats and oils markets held steady on Friday December 27, with limited trades persisting due to the holiday season.

Weekly averages were unchanged from the prior week...

12.27.2024

Relative prices of US meat and bonemeal rise amid depressed soybean meal market: 2024 recap

Relative prices of US meat and bonemeal rise amid depressed soybean meal market: 2024 recap

US animal protein prices were steady to lower on Friday December 27. Some participants reported distressed loads in the market late in the afternoon of Thursday December 26 and...

Latest Tweets